Now Playing
Workflow Moats, Crypto Infrastructure & Sweden's $5B Bet
Audio is available on Spreaker — see link below.
Startup funding is concentrating on execution over narrative — today's briefing covers AusperBio's $120M biotech signal, crypto's institutional shift, Yardstik and CivilGrid's workflow moats, and Sweden's projected $5B funding year. Six stories, sharp analysis, no noise.
Audio is available on Spreaker — see link below.
AusperBio just closed a hundred and twenty million dollar Series C to take its hepatitis B drug into Phase Three trials, and that round tells you more about where biotech capital is sitting right now than almost any single data point this week. Here's what matters.
That same pattern runs through two other rounds worth pausing on. Yardstik raised thirty million dollars and is growing revenue at a hundred and forty-nine percent year over year.
Crypto had a strong week by a specific measure. Total funding reached a hundred and eighty-four million dollars, and the composition of that number matters more than the headline.
Sweden is projecting five billion dollars in startup funding for twenty-twenty-six, up from three point two billion in twenty-twenty-five. Lovable, Legora, and Neko Health are leading the current wave, and American institutional investors are now flying in rather than waiting for founders to come to them.
Two smaller rounds complete today's picture. Transfyr raised twenty-five million to build a data observability layer for laboratory research, capturing experimental data that currently disappears between steps and can't be used to train AI systems or improve reproducibility.
The thread connecting today's activity is straightforward. Capital is going to places where the execution path is visible, the workflow is already owned, or the regulatory moat is defensible.
Chapter summary auto-generated from the verified script. Listen to the full episode for the complete content.